A new study identifies molecular factors that promote small vessel disease—and an active drug that can restore impaired ...
In a novel study, researchers from the Icahn School of Medicine at Mount Sinai introduced LoGoFunc, an advanced computational tool that predicts pathogenic gain- and loss-of-function variants across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback